Technology Transfer Capabilities
Our approach is heavily based on following CGxP documentation best practices and has been honed over a decade of proven past performance.
01
Proven Tech Transfer Toolkit
Through our extensive experience we’ve built a comprehensive suite of SOPs and templates for navigating the tech transfer process.
Explore More
02
Experts With Broad Experience
We offer expertise on all stages of tech transfer including prerequisites, project initiation, information exchange, planning, execution, and verification.
Explore More
03
Synchronized Change Process
Kymanox treats tech transfer as a change process that is synchronized with the Quality Management System (QMS) and regulatory submissions.
Explore More
04
Right First Time Execution
Kymanox helps you avoid costly and often irreversible missteps. Together with you, Kymanox helps plan and execute Right First Time Technology Transfers.
Explore More
Kymanox Technology Transfer Resources
Meet our Technology Transfer Experts
Nicole Bridgers
PRINCIPAL PROCESS ENGINEER
Helpful Links
Here are some of our favorite resources on this topic
Markets That Benefit from Our Technology Transfer Solutions
Combination Products
Our experts understand the interaction between devices and drug products. Our experience includes injectables, nasal, respiratory, and more.
Biologics & Cell and Gene Therapy Services
We understand why “the product is the process” and how to implement solutions to your unique challenges.
The Kymanox Technology Transfer Difference
We combine people, process, and systems to produce seamless tech transfers that deliver “Right First Time” solutions
Product, Process, & Relationships Approach
Our approach to a successful tech transfer includes creating a good relationship between receiving and sending sites in addition to ensuring full product and process understanding.
“Right First Time” Execution
Our branded methodology, Ideal Knowledge TransferTM, combines technical project management, fundamental engineering practices, quality and regulatory expertise, and business acumen
Proven Broad Expertise
Our team of experts is focused on life sciences with extensive experience across drug and device development. No matter your challenge, we can help you conquer it.
Frequently Asked Technology Transfer Questions (FAQs)
When is the right time to start planning Analytical Method Transfer?
Analytical Method Transfer is one of the most critical, yet usually initially neglected, activities during tech transfers. Many companies underestimate the time method transfers can take. All the associated materials need to be identified, ordering of the materials, and planning of the transfer need to be assessed at the very beginning of the project. At Kymanox, we create and manage a very detailed tech transfer timeline by talking to all stakeholders, ensuring nothing is neglected that can push out the timeline.
What is technology transfer?
Every time your organization contemplates moving a product from one location (e.g. lab, manufacturing facility, country) to another, you enter the domain of technology transfer.
The technology transfer process is complex with multiple steps performed in a specific order, requiring a significant resource commitment from many different groups at both the transferring, and the receiving organizations, for activities often spanning many months. A successful technology transfer requires comprehensive planning, effective coordination and first-time-right execution, in order to meet often aggressive deadlines.
Read the Latest at Kymanox
Kymanox Acquires Agilis Consulting Group, A Trusted Human Factors Provider
Kymanox Acquires Agilis Consulting Group, A Trusted Human Factors Provider
Integrating the well-respected and trusted Agilis brand and team extends Kymanox’s capabilities in human factors (HF) by adding incredible talent, the ability to conduct HF stu...
Investment Reports Interview with Stephen M. Perry, CEO and Founder of Kymanox
Kymanox CEO and Founder, Stephen M. Perry was interviewed as part of the Investment Reports article, The New Era of Life Sciences 2023, published on 17MAR23,
What were the circumstances that brought Kymanox to life and what does your present foo...
Kymanox Acquires EU Based Anteris Medical and Anteris Helvetia
Leveraging the well-respected anteris brand and team, this acquisition extends Kymanox’s capabilities and geographic reach with a strong European presence
Friday, 03 February 2023
Morrisville, North Carolina, USA and Holzkirchen, Germany an...